Aimei Health Technology (AFJK) Stock Price, News & Analysis

Company Overview

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Key Stats

• Today's Range: $11.18 to $11.18
• 50-Day Range: $10.97 to $11.22
• 52-Week Range: $10.24 to $11.20
• Volume: 1,127 shs
• Average Volume: 36,048 shs
• Market Capitalization: $68.32 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AFJK Stock Analysis - Frequently Asked Questions

How have AFJK shares performed this year?

Aimei Health Technology's stock was trading at $10.70 at the beginning of 2025. Since then, AFJK stock has increased by 4.3% and is now trading at $11.16.
View the best growth stocks for 2025 here.

How were Aimei Health Technology's earnings last quarter?

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) announced its quarterly earnings results on Friday, March, 28th. The company reported $0.05 EPS for the quarter.

Who are Aimei Health Technology's major shareholders?

Top institutional shareholders of Aimei Health Technology include Mizuho Securities USA LLC (8.98%), Wolverine Asset Management LLC (6.66%), Quarry LP (2.57%) and Polar Asset Management Partners Inc. (0.16%).

How do I buy shares of Aimei Health Technology?

Shares of AFJK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Aimei Health Technology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aimei Health Technology investors own include Andretti Acquisition Corp. II (POLEU), Arogo Capital Acquisition (AOGO), Agriculture & Natural Solutions Acquisition (ANSC), Alpha Star Acquisition (ALSA), Alchemy Investments Acquisition Corp 1 (ALCY), AI Transportation Acquisition (AITR) and Aimfinity Investment Corp. I (AIMAU).

Company Calendar

• Last Earnings: 3/28/2025
• Today: 6/18/2025
• Next Earnings (Estimated): 6/27/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Unclassified
• Industry: UNCLASSIFIED
• Sub-Industry: Trading
• Current Symbol: NASDAQ:AFJK
• Previous Symbol: NASDAQ:AFJK
• CIK: 1979005
• Web: N/A
• Phone: 34-67-803-5200
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $2.55 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -151.33%
• Return on Assets: 3.02%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: $0.28 per share
• Price / Cash Flow: 39.44
• Book Value: ($0.16) per share
• Price / Book: -69.75

Miscellaneous

• Outstanding Shares: 6,120,000
• Free Float: 6,018,000
• Market Cap: $68.30 million
• Optionable: N/A
• Beta: -0.02